Open access
Open access
Powered by Google Translator Translator

Immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

16 Aug, 2017 | 21:00h | UTC

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes – Science Translational Medicine (free)

Commentary: Immunotherapy Promising for Diabetes: Study – The Scientist (free) AND Study: Immunotherapy Halts Insulin Destruction in Type 1 Diabetes – AJMC (free) AND Immunotherapy for Type 1 Diabetes Safe, Promising in Small Study – Medscape (free registration required)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.